| 1 |
Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain, 1949, 72: 373- 381.
doi: 10.1093/brain/72.3.373
|
| 2 |
Sosunov A, Olabarria M, Goldman JE. Alexander disease: an astrocytopathy that produces a leukodystrophy. Brain Pathol, 2018, 28: 388- 398.
doi: 10.1111/bpa.12601
|
| 3 |
Hagemann TL. Alexander disease: models, mechanisms, and medicine. Curr Opin Neurobiol, 2022, 72: 140- 147.
doi: 10.1016/j.conb.2021.10.002
|
| 4 |
Messing A. Alexander disease. Handb Clin Neurol, 2018, 148: 693- 700.
|
| 5 |
Helman G, Takanohashi A, Hagemann TL, Perng MD, Walkiewicz M, Woidill S, Sase S, Cross Z, Du Y, Zhao L, Waldman A, Haake BC, Fatemi A, Brenner M, Sherbini O, Messing A, Vanderver A, Simons C. Type Ⅱ Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform. Hum Mutat, 2020, 41: 1131- 1137.
doi: 10.1002/humu.24008
|
| 6 |
van der Knaap MS, Naidu S, Breiter SN, Blaser S, Stroink H, Springer S, Begeer JC, van Coster R, Barth PG, Thomas NH, Valk J, Powers JM. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol, 2001, 22: 541- 552.
|
| 7 |
Farina L, Pareyson D, Minati L, Ceccherini I, Chiapparini L, Romano S, Gambaro P, Fancellu R, Savoiardo M. Can MR imaging diagnose adult-onset Alexander disease?. AJNR Am J Neuroradiol, 2008, 29: 1190- 1196.
doi: 10.3174/ajnr.A1060
|
| 8 |
Sun YC, Huang YN, Zhu H, Jin HQ, Li F, Wang ZX. Clinical and gene mutation analysis on Alexander's disease type Ⅱ caused by a novel GFAP mutation. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19: 199- 204.
URL
|
|
孙云闯, 黄一宁, 朱慧, 金海强, 李凡, 王朝霞. GFAP基因新突变致罕见表现的亚历山大病临床及基因突变分析. 中国现代神经疾病杂志, 2019, 19: 199- 204.
URL
|
| 9 |
Miao M, Zhang TX, Li Y, Liang B, Zhao YY, Zhao CP, Yan CZ. Clinical analysis of type Ⅱ Alexander disease and literature review. Zhonghua Shen Jing Ke Za Zhi, 2021, 54: 470- 478.
doi: 10.3760/cma.j.cn113694-20201010-00769
|
|
苗萌, 张同霞, 李岩, 梁兵, 赵玉英, 赵翠萍, 焉传祝. 亚历山大病Ⅱ型临床特点分析并文献复习. 中华神经科杂志, 2021, 54: 470- 478.
doi: 10.3760/cma.j.cn113694-20201010-00769
|
| 10 |
Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, Fain D, Fernandez R, Ferreira J, Fleming J, Gill D, Griebel M, Heilstedt H, Kaplan P, Lewis D, Nakagawa M, Pedersen R, Reddy A, Sawaishi Y, Schneider M, Sherr E, Takiyama Y, Wakabayashi K, Gorospe JR, Vanderver A. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology, 2011, 77: 1287- 1294.
doi: 10.1212/WNL.0b013e3182309f72
|
| 11 |
Yoshida T, Sasaki M, Yoshida M, Namekawa M, Okamoto Y, Tsujino S, Sasayama H, Mizuta I, Nakagawa M, Alexander Disease Study Group in Japan. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neurol, 2011, 258: 1998- 2008.
doi: 10.1007/s00415-011-6056-3
|
| 12 |
Davison JE, Davies NP, English MW, Philip S, MacPherson LK, Gissen P, Peet AC. Magnetic resonance spectroscopy in the diagnostic evaluation of brainstem lesions in Alexander disease. J Child Neurol, 2011, 26: 356- 360.
doi: 10.1177/0883073810381279
|
| 13 |
van der Voorn JP, Pouwels PJ, Salomons GS, Barkhof F, van der Knaap MS. Unraveling pathology in juvenile Alexander disease: serial quantitative MR imaging and spectroscopy of white matter. Neuroradiology, 2009, 51: 669- 675.
doi: 10.1007/s00234-009-0540-9
|
| 14 |
Casasnovas C, Verdura E, Vélez V, Schlüter A, Pons-Escoda A, Homedes C, Ruiz M, Fourcade S, Launay N, Pujol A. A novel mutation in the GFAP gene expands the phenotype of Alexander disease. J Med Genet, 2019, 56: 846- 849.
doi: 10.1136/jmedgenet-2018-105959
|
| 15 |
Ratai EM, Gilberto González R. Clinical magnetic resonance spectroscopy of the central nervous system. Handb Clin Neurol, 2016, 135: 93- 116.
|
| 16 |
Brockmann K, Dechent P, Meins M, Haupt M, Sperner J, Stephani U, Frahm J, Hanefeld F. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol, 2003, 250: 300- 306.
doi: 10.1007/s00415-003-0995-2
|
| 17 |
Fujima N, Carlota Andreu-Arasa V, Barest GD, Srinivasan A, Sakai O. Magnetic resonance spectroscopy of the head and neck: principles, applications, and challenges. Neuroimaging Clin N Am, 2020, 30: 283- 293.
doi: 10.1016/j.nic.2020.04.006
|
| 18 |
Weinberg BD, Kuruva M, Shim H, Mullins ME. Clinical applications of magnetic resonance spectroscopy tumors: from diagnosis to treatment. Radiol Clin North Am, 2021, 59: 349- 362.
doi: 10.1016/j.rcl.2021.01.004
|
| 19 |
Scheau C, Preda EM, Popa GA, Ghergus AE, Lupescu IG. Magnetic resonance spectroscopy: a non-invasive method in evaluating focal and diffuse central nervous system disease. J Med Life, 2012, 5: 423- 427.
|
| 20 |
Tomiyasu M, Harada M. In vivo human MR spectroscopy using a clinical scanner: development, applications, and future prospects. Magn Reson Med Sci, 2022, 21: 235- 252.
doi: 10.2463/mrms.rev.2021-0085
|
| 21 |
Bizzi A, Castelli G, Bugiani M, Barker PB, Herskovits EH, Danesi U, Erbetta A, Moroni I, Farina L, Uziel G. Classification of childhood white matter disorders using proton MR spectroscopic imaging. AJNR Am J Neuroradiol, 2008, 29: 1270- 1275.
doi: 10.3174/ajnr.A1106
|
| 22 |
Martucci M, Russo R, Giordano C, Schiarelli C, D'Apolito G, Tuzza L, Lisi F, Ferrara G, Schimperna F, Vassalli S, Calandrelli R, Gaudino S. Advanced magnetic resonance imaging in the evaluation of treated glioblastoma: a pictorial essay. Cancers (Basel), 2023, 15: 3790.
doi: 10.3390/cancers15153790
|
| 23 |
Gonçalves FG, Chawla S, Mohan S. Emerging MRI to redefine treatment response in patients with glioblastoma. J Magn Reson Imaging, 2020, 52: 978- 997.
doi: 10.1002/jmri.27105
|
| 24 |
Swanberg KM, Landheer K, Pitt D, Juchem C. Quantifying the metabolic signature of multiple sclerosis by in vivo proton magnetic resonance spectroscopy: current challenges and future outlook in the translation from proton signal to diagnostic biomarker. Front Neurol, 2019, 10: 1173.
doi: 10.3389/fneur.2019.01173
|
| 25 |
Joyce JM, La PL, Walker R, Harris AD. Magnetic resonance spectroscopy of traumatic brain injury and subconcussive hits: a systematic review and Meta-analysis. J Neurotrauma, 2022, 39: 1455- 1476.
doi: 10.1089/neu.2022.0125
|